Rbf Capital, LLC Verastem, Inc. Transaction History

Rbf Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.79 - $4.09 $372,518 - $546,092	-133,519 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $431,266 - $935,968	133,519 New	133,519 $449,000
Q2 2018 Aug 14, 2018	SELL	$2.88 - $8.67 $33,350 - $100,398	-11,580 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.01 - $5.41 $34,855 - $62,647	11,580	11,580 $55,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $565M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Rbf Capital, LLC with notifications on news.